As of 2024-12-15, the Relative Valuation of Utah Medical Products Inc (UTMD) is 182.30 USD. This relative valuation is based on P/E multiples. With the latest stock price at 62.91 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 189.8%.
The range of the Relative Valuation is 142.61 - 228.10 USD.
| Range | Selected | |
| Trailing P/E multiples | 43.0x - 50.7x | 47.8x |
| Forward P/E multiples | 36.3x - 38.7x | 38.0x |
| Fair Price | 142.61 - 228.10 | 182.30 |
| Upside | 126.7% - 262.6% | 189.8% |
| Date | P/E |
| 2024-12-12 | 14.14 |
| 2024-12-11 | 14.21 |
| 2024-12-10 | 14.15 |
| 2024-12-09 | 14.13 |
| 2024-12-06 | 14.18 |
| 2024-12-05 | 14.16 |
| 2024-12-04 | 14.28 |
| 2024-12-03 | 14.31 |
| 2024-12-02 | 14.53 |
| 2024-11-29 | 14.50 |
| 2024-11-27 | 14.47 |
| 2024-11-26 | 14.48 |
| 2024-11-25 | 14.66 |
| 2024-11-22 | 14.51 |
| 2024-11-21 | 14.35 |
| 2024-11-20 | 14.26 |
| 2024-11-19 | 14.37 |
| 2024-11-18 | 14.68 |
| 2024-11-15 | 14.67 |
| 2024-11-14 | 14.78 |
| 2024-11-13 | 14.88 |
| 2024-11-12 | 15.19 |
| 2024-11-11 | 15.22 |
| 2024-11-08 | 15.09 |
| 2024-11-07 | 14.94 |
| 2024-11-06 | 14.92 |
| 2024-11-05 | 14.22 |
| 2024-11-04 | 14.36 |
| 2024-11-01 | 14.24 |
| 2024-10-31 | 14.08 |
| 2024-10-30 | 14.22 |
| 2024-10-29 | 14.25 |
| 2024-10-28 | 14.27 |
| 2024-10-25 | 14.25 |
| 2024-10-24 | 14.28 |
| 2024-10-23 | 14.41 |
| 2024-10-22 | 14.50 |
| 2024-10-21 | 14.61 |
| 2024-10-18 | 14.73 |
| 2024-10-17 | 14.59 |
| 2024-10-16 | 14.72 |
| 2024-10-15 | 14.79 |
| 2024-10-14 | 14.78 |
| 2024-10-11 | 14.74 |
| 2024-10-10 | 14.63 |
| 2024-10-09 | 14.59 |
| 2024-10-08 | 14.45 |
| 2024-10-07 | 14.46 |
| 2024-10-04 | 14.45 |
| 2024-10-03 | 14.51 |